ラサギリン
1007/978-3-7091-7494-4_9. PMID 8988465.
↑ “Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease”. CNS Drugs 22 (7): 563–86. (2008). doi:10.2165/00023210-200822070-00003. PMID 18547126.
1 2 3 “Rasagiline for the treatment of Parkinson's disease: an update”. Expert Opinion on Pharmacotherapy 16 (14): 2231–41. (2015). doi:10.1517/14656566.2015.1086748. PMID 26364897.
↑ “Therapeutic advances in multiple system atrophy and progressive supranuclear palsy”. Movement Disorders 30 (11): 1528–38. (September 2015). doi:10.1002/mds.26334. PMID 26227071.
1 2 3 4 5 6 7 8 9 Azilect Prescribing Information Label last revised May, 2014
↑ “From a Parkinson's disease expert: Rasagiline and the future of therapy”.